Cargando…
Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation
Micheliolide (MCL) has shown promising anti-inflammatory and anti-tumor efficacy. However, whether and how MCL enhances the sensitivity of non-small-cell lung cancer (NSCLC) to radiotherapy are still unknown. In the present paper, we found that MCL exerted a tumor cell killing effect on NSCLC cells...
Autores principales: | Kong, Peizhong, Yu, K.N., Yang, Miaomiao, Almahi, Waleed Abdelbagi, Nie, Lili, Chen, Guodong, Han, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247679/ https://www.ncbi.nlm.nih.gov/pubmed/32403326 http://dx.doi.org/10.3390/ijms21093392 |
Ejemplares similares
-
Properties and gene expression profiling of acquired radioresistance in mouse breast cancer cells
por: Qin, Feng, et al.
Publicado: (2021) -
Micheliolide suppresses LPS-induced neuroinflammatory responses
por: Sun, Zhaomeng, et al.
Publicado: (2017) -
Micheliolide prevents estrogen deficiency-induced bone loss via inhibiting osteoclast bone resorption
por: Gan, Ziyang, et al.
Publicado: (2023) -
(E)-13-(2-Bromophenyl)micheliolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014) -
HIF-1 and tumour radiosensitivity
por: Moeller, B J, et al.
Publicado: (2006)